Join to View Full Profile
3601 Pierce AveNashville, TN 37232
Phone+1 615-936-2000
Fax+1 615-936-0605
Dr. Byrne is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 2014 - 2015
University of FloridaFellowship, Hematology and Medical Oncology, 2011 - 2014
Cleveland Clinic FoundationCertificate, Medical Education, 2009 - 2010
Cleveland Clinic FoundationResidency, Internal Medicine, 2007 - 2010
Lake Erie College of Osteopathic Medicine - Seton HillClass of 2007
Certifications & Licensure
KY State License 2021 - 2026
TN State License 2015 - 2026
AL State License 2020 - 2025
CA State License 2014 - 2016
OH State License 2007 - 2011
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- ASH Travel Award Florida Society of Clinical Oncology, 2013
- Fellow Travel Award - 23rd Annual Mayo Clinic Hematology/Oncology Reviews Mayo Clinic, 2013
- Inductee Psi Sigma Alpha - Osteopathic Honor Society (top 5% of graduates), 2007
- Join now to see all
Publications & Presentations
PubMed
- Who Is Eligible for CAR T-Cell Therapy? Expert Perspectives on Overcoming Referral Barriers.Mazyar Shadman, Sairah Ahmed, Michael T Byrne, Julio C Chavez, Manali Kamdar
Transplantation and Cellular Therapy. 2025-10-23 - 3 citationsZUMA-8: a phase 1 study of brexucabtagene autoleucel in patients with relapsed/refractory chronic lymphocytic leukemia.Matthew S Davids, Saad S Kenderian, Ian Flinn, Brian T Hill, Michael Maris
Blood. 2025-08-21 - 2 citationsKey Challenges in CAR T-Cell Therapy Access in Community Oncology.Michael T Byrne, Aaron J Lyss, Samyukta Mullangi
JAMA Oncology. 2025-05-01
Books/Book Chapters
Press Mentions
OneOncology Appoints Dr. Michael Byrne as Medical Director for Cellular TherapyJuly 7th, 2025
Grant Support
- Stratification of PKR expression as a biomarker in acute leukemiaClinical and Translational Science Institute, University of Florida2013
Committees
- Committee Member, UCSF Hematologic Malignancies Site Committee 2014 - Present
- Committee Member, UCSF Early Phase Site Committee 2014 - Present
- Committee Member, UCSF Fellowship Program Steering Committee 2014 - Present
- Committee Member, Florida Society of Clinical Oncology Program Committee 2013 - 2014
- Committee Member, Florida Society of Clinical Oncology Committee on Brand Redevelopment 2013 - 2014
- Committee Member, Cleveland Clinic Residency Advisory Panel 2007 - 2010
Professional Memberships
- Member
- Member
- Member
- Member
- American Society of Blood and Marrow TransplantationMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
